SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-006551
Filing Date
2024-05-02
Accepted
2024-05-02 16:20:39
Documents
57
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20240331x10q.htm   iXBRL 10-Q 947072
2 EX-31.1 nxtc-20240331xex31d1.htm EX-31.1 12899
3 EX-31.2 nxtc-20240331xex31d2.htm EX-31.2 12680
4 EX-32.1 nxtc-20240331xex32d1.htm EX-32.1 12237
  Complete submission text file 0001558370-24-006551.txt   4711243

Data Files

Seq Description Document Type Size
5 EX-101.SCH nxtc-20240331.xsd EX-101.SCH 29408
6 EX-101.CAL nxtc-20240331_cal.xml EX-101.CAL 39663
7 EX-101.DEF nxtc-20240331_def.xml EX-101.DEF 109789
8 EX-101.LAB nxtc-20240331_lab.xml EX-101.LAB 318835
9 EX-101.PRE nxtc-20240331_pre.xml EX-101.PRE 215178
61 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20240331x10q_htm.xml XML 803142
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 24908650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)